LAG3 and neoplasm: In mice, single LAG-3 knockout did not lead to development of disease, but it was demonstrated that inhibition or deficiency of Gal-3 activated CD8 T-cells specifically in the tumor microenvironment, suggesting an anti-tumor effect much like PD-L1 inhibition (Kouo et al., 2015).